Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Progressive multifocal leukoencephalopathy


Other Names for this Disease

  • Leukoencephalopathy, progressive multifocal
  • PML
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Newline Maker

How might progressive multifocal leukoencephalopathy (PML) be treated?

Currently, the best available therapy is reversal of the immune-deficient state. This can sometimes be accomplished by alteration of chemotherapy or immunosuppression. In the case of HIV-associated PML, immediately beginning anti-retroviral therapy will benefit most individuals.[1]
Last updated: 3/3/2011

References
  1. NINDS Progressive Multifocal Leukoencephalopathy Information Page. National Institute of Neurological Disorders and Stroke (NINDS). 2010; http://www.ninds.nih.gov/disorders/pml/pml.htm. Accessed 3/3/2011.


Clinical Trials & Research for this Disease

  • ClinicalTrials.gov lists trials that are studying or have studied Progressive multifocal leukoencephalopathy. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
Other Names for this Disease
  • Leukoencephalopathy, progressive multifocal
  • PML
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.